high-sustained factor & non-factor replacement therapy: reducing treatment burden in hemophilia
Published 6 months ago • 83 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
8:02
s2e4 - how to determine factor levels in hemophilia?
-
1:02
maintenance therapy following treatment for amyloidosis
-
27:50
a history of hemophilia treatment non replacement therapy to gene therapy
-
2:13
haploidentical sct for the treatment of secondary aml
-
6:22
the value of hemophilia comprehensive care
-
3:21
ehl factor concentrates | your questions answered | haemnet | cc animation studio
-
32:25
a history of hemophilia treatment factor replacement to gene therapy
-
2:53
factor replacement therapy
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
2:41
an overview of the latest advances in hematology
-
3:23
new approaches to hemophilia research
-
1:47
shared treatment decision-making
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:38
optimal time for allo-hsct in aml
-
2:35
ehl factor concentrates - what you need to know | haemnet | creative connection
-
18:51
isth academy presentation: half-life extended factor viii for the treatment of hemophilia a
-
41:44
optimizing prophylactic management of hemophilia with novel and emerging non-factor therapies
-
2:03
evaluating germline variant gfi1-36n and its impact on dna repair in aml